Treatment of infected tibial nonunion with tobramycin-impregnated calcium sulfate: Report of two cases

Chang Gung Medical Journal

Volumn 27, Issue 7, 2004, Pages 542-547

  Tsai, Yao Hung ^a   Huang, Tsung Jen ^a   Shih, Hsin Nung ^a   Hsu, Robert Wen Wei ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Osteomyelitis; Osteoset; Tibia

Indexed keywords

BONE CEMENT; CALCIUM SULFATE; GENTAMICIN; OXACILLIN; TOBRAMYCIN;

ADULT; ALLOGRAFT; ANTIBIOTIC RESISTANCE; ARTICLE; AUTOGRAFT; BONE GRAFT; BONE INFECTION; BONE PLATE; CASE REPORT; DEBRIDEMENT; FRACTURE FIXATION; FRACTURE HEALING; HUMAN; HUMAN TISSUE; MALE; RECURRENT DISEASE; STAPHYLOCOCCUS AUREUS; SURGICAL TECHNIQUE; TIBIA; TREATMENT OUTCOME;

ACCIDENTS; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CALCIUM SULFATE; ENTEROCOCCUS FAECALIS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TIBIA; TIBIAL FRACTURES; TOBRAMYCIN; TREATMENT OUTCOME;

EID: 4544311150     PISSN: 02558270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Miclau T, Dahners LE, Lindsey RW. In vitro pharmacokinetics of antibiotic release from locally implantable materials. J Orthop Res 1993;11:627-32.
2. Ueng WN, Wei FC, Shih CH. Management of femoral diaphyseal infected nonunion with antibiotic beads local therapy, external skeletal fixation, and staged bone grafting. J Trauma 1999;46:97-103.
3. Blaha JD. Calcium sulfate bone-void filler. Orthopedics 1998;21:1017-9.
4. Gitelis S, Haggard W, Piasecki P. Use of a calcium sulfate-based bone graft substitute for benign bone lesions. Orthopedics 2001;24:162-6.
5. Kelly CM, Wilkins RM, Gitelis S. The use of a surgical grade calcium sulfate as a bone graft substitute. Clin Orthop 2001;382:42-50.
6. Khan SN, Tomin E, Lane JM. Clinical applications of bone graft substitutes. Orthop Clin North Am 2000;31:389-409.
7. Tay BK, Patel VV, Bradford DS. Calcium sulfate and calcium phosphate based bone substitutes. Orthop Clin North Am 1999;30:615-23.
8. Richelsoph KC, Peterssen DW, Haggard WO. Elution characteristics of tobramycin-impregnated medical grade calcium sulfate hemihydrate. Trans Orthop Res Soc 1998;44:429.
9. Richelsoph KC, Ingells JF, Peterssen DW. Elution and bioactivity of vanvomycin incorporated within calcium sulfate. Trans Soc Biomater 1999;25:425.
10. Behrens F, Johnson WD. Unilateral external fixation: methods to increase and reduce frame stiffness. Clin Orthop 1989;241:8.
11. Edward CC, Simons SC, Browner BD. Severe open tibial fractures: results treating 202 injuries with external fixation. Clin Orthop 1998;230:98.
12. Henry SL, Seligson D, Mangino P. Antibiotic-impregnated beads. Part I. Bead implantation versus systemic therapy. Orthop Rev 1991;20:242.
13. Klemm K. Antibiotic bead chains. Clin Orthop 1993;259:63.
14. Papham GJ, Mangino P, Seligson D. Antibiotic-impregnated beads. Part II. Factors in antibiotics selection. Orthop Rev 1991;20:331.
15. Patzakis MJ, Kai M, Wilkin J. Septopal beads and autogenic bone grafting for bone defects in patients with chronic osteomyelitis. Clin Orthop 1993;295:112.
16. Mousset B, Benoit M, Delloye C. Biodegradable implants for potential use in bone infection. Int Orthop 1995;19:157-61.
17. Chan YS, Ueng WN, Wang CJ. Management of small infected tibial defects with antibiotic-impregnated autogenic cancellous bone grafting. J Trauma 1998;45:758-63.
18. McLaren AC, Miniaci A. In vivo study to determine the efficacy of cancellous bone graft as a delivery vehicle for antibiotics. Trans Soc Biomat 1986;12:1.
19. Bowyer GW, Cumberland N. Antibiotic release from impregnated pellets and beads. J Trauma 1994;36:331-5.